Shares of Dynegy (NYSE:DYN) have been assigned an average rating of “Hold” from the twelve research firms that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation and six have given a buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $13.01.
A number of analysts have commented on DYN shares. ValuEngine upgraded Dynegy from a “strong sell” rating to a “sell” rating in a research report on Monday, April 2nd. Zacks Investment Research upgraded Dynegy from a “hold” rating to a “buy” rating and set a $14.00 price target for the company in a research report on Friday, March 2nd. Guggenheim restated a “buy” rating on shares of Dynegy in a research report on Tuesday, April 10th. Finally, SunTrust Banks restated a “hold” rating and issued a $14.00 price target on shares of Dynegy in a research report on Tuesday, March 6th.
Best Bank Stocks To Invest In 2019: Adams Diversified Equity Fund, Inc.(ADX)
- [By Stephan Byrd]
AdEx (CURRENCY:ADX) traded 3.5% higher against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern on September 3rd. One AdEx token can currently be bought for $0.22 or 0.00003064 BTC on popular cryptocurrency exchanges including EtherDelta (ForkDelta), Bittrex, IDEX and Upbit. AdEx has a total market cap of $16.37 million and $1.48 million worth of AdEx was traded on exchanges in the last day. Over the last seven days, AdEx has traded 12% higher against the U.S. dollar.
- [By Max Byerly]
AdEx (CURRENCY:ADX) traded up 9.2% against the dollar during the twenty-four hour period ending at 18:00 PM Eastern on April 24th. In the last seven days, AdEx has traded up 47.7% against the dollar. One AdEx token can now be purchased for about $1.12 or 0.00011782 BTC on major cryptocurrency exchanges including IDEX, Huobi, EtherDelta (ForkDelta) and Liqui. AdEx has a total market cap of $81.99 million and approximately $13.84 million worth of AdEx was traded on exchanges in the last day.
- [By WWW.GURUFOCUS.COM]
For the details of Candlewood Investment Group, LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Candlewood+Investment+Group%2C+LP
These are the top 5 holdings of Candlewood Investment Group, LPPacific Ethanol Inc (PEIX) – 1,680,130 shares, 100% of the total portfolio. Shares added by 42.52%Adams Diversified Equity Fund Inc (ADX) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%Ambac Financial Group Inc (AMBC) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%JPMorgan Chase Capital XVI JP Morgan Alerian MLP E (AMJ) – 0 shares, 0% of the total portfolio. Shares reduced by 10000%VanEck Vectors Fallen Angel High Yield Bond (ANGL) – 0 shares, 0% of the total portfol
- [By Shane Hupp]
AdEx (CURRENCY:ADX) traded 2.3% lower against the U.S. dollar during the 1-day period ending at 15:00 PM E.T. on May 12th. One AdEx token can now be purchased for $0.77 or 0.00009068 BTC on major cryptocurrency exchanges including IDEX, EtherDelta (ForkDelta), Binance and Gatecoin. During the last seven days, AdEx has traded 25.9% lower against the U.S. dollar. AdEx has a total market cap of $56.24 million and $2.87 million worth of AdEx was traded on exchanges in the last day.
Best Bank Stocks To Invest In 2019: StarTek, Inc.(SRT)
- [By Shane Hupp]
ManpowerGroup (NYSE: MAN) and StarTek (NYSE:SRT) are both business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings.
- [By Ethan Ryder]
Cross Country Healthcare (NASDAQ: CCRN) and StarTek (NYSE:SRT) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.
- [By Logan Wallace]
Sartorius (ETR:SRT) received a €100.00 ($116.28) price target from research analysts at Commerzbank in a report released on Friday. The brokerage presently has a “sell” rating on the stock. Commerzbank’s target price suggests a potential downside of 17.36% from the company’s previous close.
- [By Joseph Griffin]
Shares of StarTek, Inc. (NYSE:SRT) have been assigned a consensus rating of “Hold” from the six analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $12.67.
- [By Shane Hupp]
These are some of the news stories that may have impacted Accern Sentiment’s scoring:
Get StarTek alerts:
Startek’s (SRT) CEO Chad Carlson on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) -$0.01 Earnings Per Share Expected for StarTek (SRT) This Quarter (americanbankingnews.com) StarTek (SRT) Downgraded by ValuEngine to Sell (americanbankingnews.com) Zacks: StarTek (SRT) Given $13.50 Consensus Price Target by Analysts (americanbankingnews.com) Edited Transcript of SRT earnings conference call or presentation 8-May-18 8:30pm GMT (finance.yahoo.com)
StarTek traded down $0.03, hitting $6.98, during trading hours on Friday, according to MarketBeat. The company’s stock had a trading volume of 199,000 shares, compared to its average volume of 114,323. StarTek has a 12 month low of $6.57 and a 12 month high of $14.78. The company has a market capitalization of $108.16 million, a price-to-earnings ratio of -87.25 and a beta of 0.20. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.24 and a current ratio of 2.41.
Best Bank Stocks To Invest In 2019: Corindus Vascular Robotics, Inc.(CVRS)
- [By Stephan Byrd]
Get a free copy of the Zacks research report on Corindus Vascular Robotics (CVRS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Max Byerly]
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) released its quarterly earnings results on Tuesday. The medical equipment provider reported ($0.08) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.05) by ($0.03), Bloomberg Earnings reports. The business had revenue of $1.49 million for the quarter, compared to the consensus estimate of $3.20 million. Corindus Vascular Robotics had a negative return on equity of 110.93% and a negative net margin of 323.84%.
- [By Alexander Bird]
Here are the top performers from last week…
Penny Stock Current Share Price Last Week’s Gain
Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%
While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.